An AA ahead of schedule is likely, the required due diligence and briefings has been completed and I'm feeling confident. I hope Mesoblast has their resources prepared and ready as Remestemcel-L is the new remedy for those young children facing despair through aGVHD.
An AA ahead of schedule is likely, the required due diligence...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
-0.030(2.82%) |
Mkt cap ! $1.176B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.03 | $6.062M | 5.815M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 141952 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 168190 | 28 |
View Market Depth
| Last trade - 14.09pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.04 |
Change
-0.030 ( 3.18 %) |
||||
| Open | High | Low | Volume | ||
| $1.07 | $1.08 | $1.03 | 1434343 | ||
| Last updated 14.25pm 06/06/2024 ? | |||||
| MSB (ASX) Chart |